TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7924128

Group type: EXPERIMENTAL
Intervention: lisinopril 20 mg daily for 12 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: amlodipine 10 mg daily for 12 weeks
Number of subjects: 36
Study: 3131874

Group type: EXPERIMENTAL
Intervention: Intracoronary nitroglycerin
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intracoronary diltiazem
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intracoronary propranolol
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal coronary arteries
Number of subjects: 37

Group type: COMPARATOR
Intervention: Stenotic arteries
Number of subjects: 37
Study: 4885025

Group type: EXPERIMENTAL
Intervention: sulphamethoxazole-trimethoprim combination (2:1 and 10:1)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: sulphamethoxazole-trimethoprim combination (5:1)
Number of subjects: 154

Group type: COMPARATOR
Intervention: ampicillin
Number of subjects: 154

Group type: COMPARATOR
Intervention: sulphadimidine
Number of subjects: 154
Study: 31930678

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration (24 international units)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161
Study: 30945511

Group type: EXPERIMENTAL
Intervention: Euphorbia kansui
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 28611340

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) infusion for 72 hours
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 80
Study: 25848890

Group type: EXPERIMENTAL
Intervention: Sitting with Vitamin C (VIT) - 2 vitamin C tablets (1 g and 500 mg) ingested at 30 min and 1 h 30 min, respectively
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sitting without Vitamin C (SIT)
Number of subjects: 11
Study: 23069326

Group type: EXPERIMENTAL
Intervention: Bronchodilation
Number of subjects: 39
Study: 21172397

Group type: EXPERIMENTAL
Intervention: P. freudenreichii ET‐3 culture medium (3g solid content and 283.5μg of DHNA)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: P. freudenreichii ET‐3 culture medium (0.267g solid content and 22.5μg of DHNA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (unfermented product)
Number of subjects: 25
Study: 19901920

Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 0
Study: 16697850

Group type: COMPARATOR
Intervention: Standard therapy (outpatient behavioral therapy)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Added video instructions with standard therapy
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Home uroflowmetry biofeedback with standard therapy
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Home uroflowmetry biofeedback with standard therapy (per protocol analysis)
Number of subjects: 143
Study: 14990012

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sulindac
Number of subjects: 8

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 8

Group type: COMPARATOR
Intervention: Regular aspirin use for 30-60 months
Number of subjects: 8

Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 8
Study: 11376916

Group type: EXPERIMENTAL
Intervention: 200 mg caffeine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 400 mg caffeine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Alcohol (0.6 g/kg ethanol)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (0 mg caffeine, 0.0 g/kg ethanol)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Caffeine alone (0 mg caffeine)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stroop and CFF performance
Number of subjects: 15
Study: 9400342

Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (up to 60 mg/d)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 8480929

Group type: EXPERIMENTAL
Intervention: Cefoxitin (3 doses)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ceftizoxime (2 doses)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Mezlocillin (3 doses)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 102
Study: 3079009

Group type: EXPERIMENTAL
Intervention: Iron succinylprotein complex (80 mg of elemental iron daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iron gluconate complex (125 mg of elemental iron daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Iron succinylprotein complex
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iron gluconate complex
Number of subjects: 40
Study: 29272211

Group type: EXPERIMENTAL
Intervention: omega‐3 (1 g/twice daily)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: cranberry juice (200 ml, twice daily)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: cranberry juice enriched with omega‐3 (200 ml, containing 1 g omega‐3, twice daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (n = 12)
Number of subjects: 41
Study: 28167331

Group type: EXPERIMENTAL
Intervention: Dampening appraisals
Number of subjects: 43

Group type: COMPARATOR
Intervention: Emotion-focus amplifying
Number of subjects: 43

Group type: COMPARATOR
Intervention: Self-focus amplifying
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control instructions
Number of subjects: 43
Study: 26182775

Group type: EXPERIMENTAL
Intervention: Sub-fascial local anaesthetic (LA) inguinal field block with 20 ml 0.5% bupivacaine, 20 ml 2% lignocaine with adrenaline, 20 ml normal saline, 3 ml NaHCO3
Number of subjects: 62

Group type: COMPARATOR
Intervention: Spinal Anaesthesia (SA) with 0.5% Bupivacaine
Number of subjects: 62
Study: 24163113

Group type: EXPERIMENTAL
Intervention: 5mg saxagliptin q.d.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 100mg sitagliptin q.d.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 50mg vildagliptin q.d.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 50mg vildagliptin b.i.d.
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 21970981

Group type: EXPERIMENTAL
Intervention: FX05 oxygenator
Number of subjects: 40

Group type: COMPARATOR
Intervention: RX05 + arterial filter
Number of subjects: 40
Study: 19160857

Group type: EXPERIMENTAL
Intervention: Intratympanic prednisolone injection
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone injection
Number of subjects: 73

Group type: COMPARATOR
Intervention: Carbamazepine (oral administration)
Number of subjects: 73
Study: 16899101

Group type: EXPERIMENTAL
Intervention: Enamel matrix protein derivative (EMD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR)
Number of subjects: 51
Study: 16281653

Group type: EXPERIMENTAL
Intervention: Active cycle of breathing techniques (ACBT) incorporating postural drainage (PD) and vibration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Test of incremental respiratory endurance (TIRE)
Number of subjects: 20
Study: 11372003

Group type: EXPERIMENTAL
Intervention: 1 mg/mL aspartame
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 2 mg/mL aspartame
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 6 mg/kg aspartame (in vivo)
Number of subjects: 43
Study: 9181653

Group type: EXPERIMENTAL
Intervention: Albendazole continuous therapy for 6 months
Number of subjects: 12

Group type: COMPARATOR
Intervention: Albendazole discontinuous therapy for 6 courses of 4 weeks with a 2 week drug-free interval
Number of subjects: 12
Study: 8215860

Group type: EXPERIMENTAL
Intervention: DYN 1x/wk (n = 14)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DYN-IM 1x/wk (n = 16)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DYN 2x/wk (n = 19)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DYN-IM 2x/wk (n = 10)
Number of subjects: 78

Group type: COMPARATOR
Intervention: CONT (n = 19)
Number of subjects: 78
Study: 3327669

Group type: EXPERIMENTAL
Intervention: Pirprofen (400 mg, b.i.d.)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo (b.i.d.)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Naproxen (250 mg, b.i.d.)
Number of subjects: 82
Study: 31622777

Group type: EXPERIMENTAL
Intervention: GIP infusion at 1.5pmol/kg/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GIP + GIP(3‐30)NH2 infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GIP infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GIP(3‐30)NH2 infusion
Number of subjects: 10
Study: 31100769

Group type: EXPERIMENTAL
Intervention: Lay observers reviewing 2D photographs of patients with unilateral enophthalmos
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (0 mm difference between eyes)
Number of subjects: 60
Study: 28779925

Group type: EXPERIMENTAL
Intervention: Low back massage
Number of subjects: 62
Study: 26295732

Group type: EXPERIMENTAL
Intervention: 3% nebulised hypertonic saline (HS) every ± 6 hours
Number of subjects: 317

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: 3% nebulised hypertonic saline (HS)
Number of subjects: 317
Study: 23628854

Group type: EXPERIMENTAL
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 3899

Group type: COMPARATOR
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 3899

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 3899
Study: 20957469

Group type: EXPERIMENTAL
Intervention: Multimodal pain control (group 1)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (group 2)
Number of subjects: 70
Study: 19036078

Group type: EXPERIMENTAL
Intervention: Chlorambucil
Number of subjects: 231

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 231
Study: 17315273

Group type: EXPERIMENTAL
Intervention: NGT decompression
Number of subjects: 200

Group type: COMPARATOR
Intervention: No NGT decompression
Number of subjects: 200
Study: 15498060

Group type: EXPERIMENTAL
Intervention: 3 mL sub-Tenon's anaesthetic (0.5% bupivacaine/2% lidocaine in a 50:50 mixture)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 5 mL sub-Tenon's anaesthetic (0.5% bupivacaine/2% lidocaine in a 50:50 mixture)
Number of subjects: 52
Study: 11574361

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 8
Study: 9439539

Group type: EXPERIMENTAL
Intervention: Complicated falciparum malaria patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 14
Study: 8200219

Group type: EXPERIMENTAL
Intervention: 250 micrograms levonorgestrel in combination with 50 micrograms ethinylestradiol
Number of subjects: 12

Group type: COMPARATOR
Intervention: 250 micrograms norgestimate in combination with 35 micrograms ethinylestradiol
Number of subjects: 12
Study: 3300988

Group type: EXPERIMENTAL
Intervention: Cefatrizine once daily (75 mg/kg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefatrizine twice daily (75 mg/kg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Erythromycin (50 mg/kg/day in three divided doses)
Number of subjects: 30
Study: 31365834

Group type: EXPERIMENTAL
Intervention: Vitamin A fortified oil (FO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-fortified oil (NFO)
Number of subjects: 0
Study: 30203327

Group type: EXPERIMENTAL
Intervention: Antidepressant monotherapies and combinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychotherapy alone or in combination with an antidepressant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Measurement-based care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer-term follow-up
Number of subjects: 0
Study: 28732650

Group type: EXPERIMENTAL
Intervention: Exemestane (25 mg once a day for 5 years)
Number of subjects: 6120

Group type: COMPARATOR
Intervention: Sequential tamoxifen (20 mg once a day for 2.5-3.0 years) followed by exemestane for a total duration of 5 years
Number of subjects: 6120
Study: 25193796

Group type: EXPERIMENTAL
Intervention: Texting and walking in a low-distraction environment (no-priority condition)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Texting and walking in a high-distraction environment (real-world setting)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Texting and walking in laboratory settings (gait-priority and texting-priority conditions)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Texting and walking in laboratory and real-world settings
Number of subjects: 32
Study: 23629558

Group type: EXPERIMENTAL
Intervention: CORFIS
Number of subjects: 486

Group type: COMPARATOR
Intervention: Control
Number of subjects: 486
Study: 21874936

Group type: EXPERIMENTAL
Intervention: Adper Single Bond Plus (SBP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ambar (AMB)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Excite (EXC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (distilled water for 24 hours at 37 degrees C)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Thermocycled (TC) for 20,000 cycles (5‐55 degrees C)
Number of subjects: 24
Study: 19801008

Group type: EXPERIMENTAL
Intervention: Incision and drainage without dressing changes
Number of subjects: 16

Group type: COMPARATOR
Intervention: Postoperative dressing changes
Number of subjects: 16
Study: 17100723

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40-80 mg daily
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2102
Study: 12795643

Group type: EXPERIMENTAL
Intervention: Insulin‐intensive conventional treatment (ICT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Insulin‐standard treatment (ST)
Number of subjects: 54
Study: 10725288

Group type: EXPERIMENTAL
Intervention: Rectilinear biphasic shocks (70, 120, 150, 170 J)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Damped sine wave monophasic shocks (100, 200, 300, 360 J)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Rectilinear biphasic shocks
Number of subjects: 165

Group type: COMPARATOR
Intervention: Damped sine wave monophasic shocks
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Biphasic waveform
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Transthoracic impedance
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Duration of atrial fibrillation
Number of subjects: 165
Study: 8933299

Group type: EXPERIMENTAL
Intervention: Face-to-face prescribing discussion visits led by a pharmaceutical prescribing adviser (Group 1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Practice specific prescribing analysis workbooks (Group 2)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Self-selected control group (Group 3)
Number of subjects: 66
Study: 1414555

Group type: EXPERIMENTAL
Intervention: Oxiracetam (1600 mg/day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 3873511

Group type: EXPERIMENTAL
Intervention: Single dose trimethoprim-sulfamethoxazole
Number of subjects: 203

Group type: COMPARATOR
Intervention: Ten-day trimethoprim-sulfamethoxazole treatment
Number of subjects: 203
Study: 30022331

Group type: EXPERIMENTAL
Intervention: Bilateral Dysport® injections (50+50 units)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Unilateral Dysport® injections (100 units)
Number of subjects: 100
Study: 26417957

Group type: EXPERIMENTAL
Intervention: Lateral position
Number of subjects: 168
Study: 24886398

Group type: EXPERIMENTAL
Intervention: FACETS plus current local practice (FACETS)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Current local practice alone (CLP)
Number of subjects: 164
Study: 21254871

Group type: EXPERIMENTAL
Intervention: 30 μg of ethinyl estradiol (EE)/3 mg of drospirenone (DRSP) plus 100 mg of cyproterone acetate (CPA)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 30 μg of EE/3 mg of DRSP plus 100 mg of spironolactone
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: 35 μg of EE/2 mg of CPA plus 100 mg of CPA
Number of subjects: 134
Study: 19728070

Group type: EXPERIMENTAL
Intervention: Alcoholic drinks (target blood alcohol content of .06, .08, or .10%)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Non-alcoholic drinks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: CSA women
Number of subjects: 64

Group type: COMPARATOR
Intervention: NSA and ASA women
Number of subjects: 64
Study: 18727456

Group type: EXPERIMENTAL
Intervention: [methyl‐13C]‐methionine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: L‐methionine‐1‐13COOH
Number of subjects: 15
Study: 16166189

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12087783

Group type: EXPERIMENTAL
Intervention: Pilot program for smoking cessation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 28)
Number of subjects: 20
Study: 10944138

Group type: EXPERIMENTAL
Intervention: Donor lymphocyte infusions (DLI)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Reinduction therapy before DLI
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: DLI
Number of subjects: 27
Study: 8839865

Group type: EXPERIMENTAL
Intervention: K-ras mutations
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: VBMCP treatment
Number of subjects: 160

Group type: COMPARATOR
Intervention: VBMCP + interferon-alpha
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: VBMCP + alternating high doses of cyclophosphamide + prednisone
Number of subjects: 160
Study: 1592959

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: COMPARATOR
Intervention: No-pill condition
Number of subjects: 66
Study: 6375611

Group type: EXPERIMENTAL
Intervention: IVT team maintained IV catheters
Number of subjects: 863

Group type: COMPARATOR
Intervention: Ward staff maintained IV catheters
Number of subjects: 863
Study: 31672709

Group type: EXPERIMENTAL
Intervention: Standard PEEP (6-8 cm H2O)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Low PEEP (≤2 cm H2O)
Number of subjects: 208
Study: 30621562

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab treatment plus ZQMT
Number of subjects: 144

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab treatment alone
Number of subjects: 144
Study: 26979174

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 1710

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1710
Study: 25248996

Group type: EXPERIMENTAL
Intervention: SASA! community mobilization intervention
Number of subjects: 2583
Study: 22646056

Group type: EXPERIMENTAL
Intervention: Left lateral-to-tilt position
Number of subjects: 51

Group type: COMPARATOR
Intervention: Supine-to-tilt position
Number of subjects: 51
Study: 20353026

Group type: EXPERIMENTAL
Intervention: Er'zhi Tiangui Granule (ETG)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Liuwei Dihuang Granule (LDG)
Number of subjects: 57
Study: 16757485

Group type: EXPERIMENTAL
Intervention: Spa treatment
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 224

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Dutch FIQ
Number of subjects: 224
Study: 15749042

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg daily for 3 days)
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 509
Study: 11423507

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 8 mg daily
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) 4 mg daily
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 319
Study: 9404750

Group type: EXPERIMENTAL
Intervention: Peak flow-based action plan
Number of subjects: 150

Group type: COMPARATOR
Intervention: Symptom-based action plan
Number of subjects: 150

Group type: COMPARATOR
Intervention: No action plan
Number of subjects: 150
Study: 8356999

Group type: EXPERIMENTAL
Intervention: nabumetone
Number of subjects: 4411

Group type: COMPARATOR
Intervention: comparator NSAIDs
Number of subjects: 4411

Group type: COMPARATOR
Intervention: diclofenac
Number of subjects: 4411

Group type: COMPARATOR
Intervention: naproxen
Number of subjects: 4411

Group type: COMPARATOR
Intervention: piroxicam
Number of subjects: 4411

Group type: COMPARATOR
Intervention: ibuprofen
Number of subjects: 4411
Study: 3314750

Group type: EXPERIMENTAL
Intervention: Graded-sequential filling
Number of subjects: 136

Group type: COMPARATOR
Intervention: Uniform compression - multiple compartments
Number of subjects: 136

Group type: COMPARATOR
Intervention: Uniform pressure - single bladder
Number of subjects: 136
Study: 2694799

Group type: EXPERIMENTAL
Intervention: 125 mg of Madopar HBS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 4593130

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ephedrine with theophylline
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline (as an addition to ephedrine)
Number of subjects: 20
Study: 31428804

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28089709

Group type: EXPERIMENTAL
Intervention: Dietary interventions based on WHO healthy eating guidelines (increase fruits, vegetables, whole grains, dietary fibre; decrease fats, sugars, and salt)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urinary metabolite models
Number of subjects: 20
Study: 25432773

Group type: EXPERIMENTAL
Intervention: Odanacatib (50 mg once weekly)
Number of subjects: 16713

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16713
Study: 23188489

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 7376

Group type: COMPARATOR
Intervention: 2009 A(H1N1) pandemic
Number of subjects: 7376
Study: 21727175

Group type: EXPERIMENTAL
Intervention: Minimized cardiopulmonary bypass (MCPB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional cardiopulmonary bypass (CCPB)
Number of subjects: 40
Study: 19553414

Group type: EXPERIMENTAL
Intervention: Enhanced care (n = 115)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual care (n = 112)
Number of subjects: 227
Study: 16690557

Group type: EXPERIMENTAL
Intervention: Bovine colostrum tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 14961882

Group type: EXPERIMENTAL
Intervention: Ultrasound screening group
Number of subjects: 15151

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15151